CSL - Net Income

Stock Price
129.19
Daily Change
-2.63 -2.00%
Monthly
-8.26%
Yearly
-47.36%
Q2 Forecast
127.56

CSL reported $401M in Net Income for its fiscal semester ending in December of 2025.





Net Income Change Date
Alterity Therapeutics Limited AUD -6.3M 525.41K Dec/2025
Arca Biopharma USD -29.58M 694K Dec/2025
aTyr Pharma USD 24.56M 50.3M Dec/2025
Bio Path USD -976K 3.62M Sep/2025
Brainstorm Cell Therapeutics USD -2.11M 797K Sep/2025
Cara Therapeutics USD -5.53M 621K Sep/2025
CSL USD 401M 96.5M Dec/2025
Curis USD 19.36M 31.16M Dec/2025
Esperion Therapeutics USD 61.83M 93.16M Dec/2025
Immunic USD -24.37M 2.99M Sep/2024
Infinity Pharmaceuticals USD -9.96M 1.09M Jun/2023
Minerva Neurosciences USD 1.44M 21.07M Dec/2024
Sangamo BioSciences USD -36.13M 12.96M Jun/2024
TherapeuticsMD USD -1.09M 356K Jun/2024